Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May-Jun;19(3):15579883251344563.
doi: 10.1177/15579883251344563. Epub 2025 Jun 23.

Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based Program

Affiliations

Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based Program

Linda Svensson et al. Am J Mens Health. 2025 May-Jun.

Abstract

This study explores aspects that men consider when deciding whether to participate in a prostate cancer screening program and how the information in the invitation letter contributed to their decision. Semi-structured interviews were conducted with 50- to 62-year-old men invited by letter to a population-based prostate cancer screening program. Data from transcribed interviews were analyzed using qualitative content analysis using manifest and indicative approaches. Eighteen men were interviewed, 10 whom chose to be tested, and 8 who declined screening. The information in the invitation letter was not decisive for whether men chose to be tested or not. The aspects that the men valued in their personal decision to participate or refrain from screening were categorized as (a) the expectation that authorities should take responsibility and provide guidance; (b) fear, which was described as both a driving force and a barrier; (c) reliance upon intuition combined with seeking social and emotional support; (d) the perception of one's own risk of being affected. Men who relied on risk assessment mentioned difficulties in evaluating the information about the potential disadvantages of screening. Our findings suggest that the intention of informed decision-making for prostate cancer screening is difficult to fully realize. Further research is needed to understand how the individual decision-making process is influenced by factors such as assessment of personal risk, perception of advantages and disadvantages, and cultural background, and to optimize the information to the invited men.

Keywords: PSA testing; decision-aid; health screening; prostate cancer; prostate-specific antigen.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Alterbeck M., Järbur E., Thimansson E., Wallström J., Bengtsson J., Björk-Eriksson T., Bjartell A., Bratt O., Jiborn T., Arnsrud Godtman R. (2022). Designing and implementing a population-based organised prostate cancer testing programme. European Urology Focus, 8, 1568–1574. 10.1016/j.euf.2022.06.008 - DOI - PubMed
    1. Auvinen A., Rannikko A., Taari K., Kujala P., Mirtti T., Kenttämies A., Rinta-Kiikka I., Lehtimäki T., Oksala N., Pettersson K., Tammela T. L. (2017). A randomized trial of early detection of clinically significant prostate cancer (ProScreen): Study design and rationale. European Journal of Epidemiology, 32(6), 521–527. 10.1007/s10654-017-0292-5 - DOI - PubMed
    1. Bell N., Gorber S. C., Shane A., Joffres M., Singh H., Dickinson J., Shaw E., Dunfield L., Tonelli M. (2014). Recommendations on screening for prostate cancer with the prostate-specific antigen test. Canadian Medical Association Journal, 186(16), 1225–1234. 10.1503/cmaj.140703. - DOI - PMC - PubMed
    1. Bratt O., Auvinen A., Arnsrud Godtman R., Hellström M., Hugosson J., Lilja H., Wallström J., Roobol M. J. (2023) Screening for prostate cancer: Evidence, ongoing trials, policies and knowledge gaps. BMJ Oncology, 2, e000039. 10.1136/bmjonc-2023-000039 - DOI - PMC - PubMed
    1. Consedine N. S., Magai C., Krivoshekova Y. S., Ryzewicz L., Neugut A. I. (2004). Fear, anxiety, worry, and breast cancer screening behavior: A critical review. Cancer Epidemiol Biomarkers & Prevention, 13, 501–510. - PubMed